During the past decade, National medical Research Center n.a. V.A.Almazov of MoH of Russian Federation conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "National medical Research Center n.a. V.A.Almazov of MoH of Russian Federation" are "Chronic Thromboembolic Pulmonary Hypertension" (2 trials), "Idiopathic Thrombocytopenic Purpura" (2 trials), "Hypertension, Pulmonary" (1 trials), "Pulmonary Arterial Hypertension" (1 trials) and "Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)" (1 trials). Many other conditions were trialed in "National medical Research Center n.a. V.A.Almazov of MoH of Russian Federation" in a lesser frequency.

Most popular intervention types in "National medical Research Center n.a. V.A.Almazov of MoH of Russian Federation" are "Drug" (5 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "GNR-069" (2 trials), "Macitentan 10 mg" (2 trials), "Selexipag" (2 trials) and "FDC macitentan/tadalafil" (1 trials). Other intervention names were less common.

The vast majority of trials in "National medical Research Center n.a. V.A.Almazov of MoH of Russian Federation" are 7 trials for "All" genders.

Currently, there are NaN active trials in "National medical Research Center n.a. V.A.Almazov of MoH of Russian Federation". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were undefined completed trials in National medical Research Center n.a. V.A.Almazov of MoH of Russian Federation, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in National medical Research Center n.a. V.A.Almazov of MoH of Russian Federation, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".